WuXi Biologics Announces Record-Breaking Full-Year 2025 Financial Results
WuXi Biologics Announces Record-Breaking Financial Performance for Fiscal Year 2025 WuXi Biologics has reported a year of strong financial performance and operational expansion for the fiscal year ending December 31,…
Celltrion Unveils KRW 1.2 Trillion Expansion of Songdo Drug Substance Facilities, Boosting Total Production Capacity to 570,000 Liters
Celltrion Unveils KRW 1.2 Trillion Investment to Expand Drug Substance Manufacturing in Songdo, Boosting Total Capacity to 570,000 Liters Celltrion has unveiled an ambitious large-scale investment strategy exceeding KRW 1…
Alnylam Expands Innovation in ATTR-CM Management with Viz.ai Partnership and American Heart Association Collaboration
Alnylam Drives Innovation in ATTR-CM Care Through Strategic Collaboration with Viz.ai and Ongoing Support for the American Heart Association Alnylam Pharmaceuticals is spearheading a comprehensive, system-wide initiative aimed at transforming…
BioNTech Showcases Promising Late-Stage Lung Cancer Portfolio with New Clinical Data at ELCC 2026
BioNTech presents new ELCC 2026 data underscoring the strength and differentiation of its late-stage lung cancer pipeline BioNTech has announced that it will showcase new clinical data from its expanding…
Dupixent Approved in Japan as the First Targeted Therapy for Adults with Bullous Pemphigoid (BP)
Dupixent Approved in Japan as the First Targeted Therapy for Adults with Bullous Pemphigoid Regeneron Pharmaceuticals and Sanofi have announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has…
AbbVie Becomes Official Pharmaceutical Partner of Major League Baseball
AbbVie Becomes Official Pharmaceutical Partner of Major League Baseball AbbVie has unveiled a landmark multi-year partnership with Major League Baseball (MLB), officially naming the company as the league’s “Official Pharmaceutical…
Celltrion Unveils KRW 1.2 Trillion Expansion of Songdo Drug Substance Facilities, Boosting Total Capacity to 570,000 Liters
Celltrion unveils KRW 1.2 trillion Songdo expansion, boosting DS production capacity by 180,000L to a total of 570,000L Celltrion has unveiled an ambitious and far-reaching investment strategy aimed at significantly…
Eylea 8 mg Secures Approval in Japan for a Third Retinal Disease Indication
Eylea™ 8 mg Secures Approval in Japan for Its Third Retinal Disease Indication The Ministry of Health, Labour and Welfare (MHLW) has granted marketing authorization in Japan for Eylea 8…
Bristol Myers Squibb Highlights Camzyos Data in oHCM at ACC 2026
Bristol Myers Squibb Strengthens Position in Obstructive Hypertrophic Cardiomyopathy with New Camzyos (mavacamten) Data Presented at ACC 2026 Bristol Myers Squibb has unveiled an extensive body of new clinical and…
Pfizer and Valneva Report Strong Phase 3 VALOR Trial Results for Lyme Disease Vaccine Candidate Demonstrating High Efficacy
Pfizer and Valneva Report Positive Phase 3 VALOR Results Showing High Efficacy for Lyme Disease Vaccine Candidate Pfizer Inc. and Valneva SE have announced encouraging topline findings from the pivotal…
Roche Opens New Institute of Human Biology to Advance Drug Discovery
Roche Launches State-of-the-Art Institute of Human Biology Facility to Advance Next-Generation Human Model Systems in Drug Discovery and Development Roche has officially inaugurated a new state-of-the-art research facility to serve…
Curi Bio and Battelle Partner to Advance Neuromuscular Pharmacology Innovations
Curi Bio and Battelle Forge Strategic Alliance to Advance New Approach Methods in Neuromuscular Pharmacology Curi Bio, a recognized leader in the development of human-relevant three-dimensional (3D) tissue platforms, has…